Shang-Gao Liao, Zhen Wang, Ya-Yun Wu, Li-Juan Zhang, Jing Li, Ai-Min Wang, Yong-Jun Li, Yan-Yu Lan, Yong-Lin Wang
Tablets of oleanolic acid (OA) have been approved by SFDA in China as an adjuvant therapy for acute and chronic hepatitis
Co-occurring substances
pentacyclic triterpenoids
cytotoxicity
sapogenins.